SPRC SciSparc Ltd: Operating Profitability

SciSparc Ltd (SPRC) is implementing software robotics for clinical data analysis, which is reflected in the operating margin, currently positioned around -660.50. The business model relies on the full outsourcing of synthesis and testing to third-party organizations. High patent barriers and the cost of neurobiological trials limit the entry of new players into this sector.
SciSparc Ltd - analytical breakdowns and key metrics (SPRC)
- share price and consensus valuation forecast:
- company stock capitalization data:
- company book value details:
- debt and liquidity data:
- net income and valuation ratios data:
SPRC - Profit After Payment of Taxes|Projected Future Earnings SciSparc Ltd|SPRC - Price to Earnings Multiple|Future Price to Earnings scisparc.com|SPRC - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SciSparc Ltd.|SPRC - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months SciSparc|SPRC - Earnings per share for the trailing year|Quarterly EPS earnings growth scisparc.com|SPRC - Net earnings per share growth this year|Net earnings per share growth forecast for next year SciSparc Ltd
- sales revenue and business income indicators:
- business margin statistics:
Comprehensive company analysis:Clearmind Medicine

Identifying fundamentally resilient assets requires analyzing a business's ability to generate earnings before interest and taxes. This metric measures the efficiency of operational processes, and in the case of SciSparc Ltd (SPRC), a strong patent portfolio in neuropharmacology minimizes pricing pressure, which is reflected in the stability of the operating EBIT margin.
Competitor analysis for SciSparc Ltd
Operating Profitability Alkermes PLC|Operating Margin Avadel Pharma|Operating Margin ATAI|GHRS (GH Research PLC) - Operating Profit Rate|MindMed - Operating Sales Margin|Operating Margin COMPASS Pathways PLC CMPS|LB Pharmaceuticals, Inc. - Operating Margin|Bright Minds Biosciences - Operating Profit Ratio|Vanda Pharmaceuticals Inc (VNDA) - Operating Profitability|CYBN - Profitability of Operations|Operating Sales Margin ANRO|NRXP: Operating Profit Rate|Operating Margin CING|SILO (silopharma.com) - Operating Profit Rate|Operating Profitability China Pharma Holdings CPHI|Operating Profit Rate CMND|PBM - Operating Profitability|Operating Profit Rate SEEL (Seelos Therapeutics, Inc.)|Virpax (VRPX) - Operating Profitability|Karuna Pharma (KRTX) - Operating Margin